700 related articles for article (PubMed ID: 18785980)
1. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
2. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
3. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
[TBL] [Abstract][Full Text] [Related]
5. [The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].
Li Y; He B; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec; 22(12):725-7. PubMed ID: 11776779
[TBL] [Abstract][Full Text] [Related]
6. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
7. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
8. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
10. A kampo medicine, Yin-Chiao-san, prevents bleomycin-induced pulmonary injury in rats.
Yen FL; Wu TH; Liao CW; Lin CC
Phytother Res; 2007 Mar; 21(3):251-8. PubMed ID: 17177325
[TBL] [Abstract][Full Text] [Related]
11. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
12. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
13. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats.
Gong LK; Li XH; Wang H; Zhang L; Chen FP; Cai Y; Qi XM; Liu LL; Liu YZ; Wu XF; Huang CG; Ren J
J Ethnopharmacol; 2005 Jan; 96(3):537-44. PubMed ID: 15619575
[TBL] [Abstract][Full Text] [Related]
14. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
15. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats.
Zhou XM; Zhang GC; Li JX; Hou J
J Ethnopharmacol; 2007 May; 111(2):255-64. PubMed ID: 17188826
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis].
Zheng JX; Lu KQ; Xia DG; Tian GR; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):808-12. PubMed ID: 20450618
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture.
Chen X; Sun R; Hu J; Mo Z; Yang Z; Liao D; Zhong N
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):278-86. PubMed ID: 18684219
[TBL] [Abstract][Full Text] [Related]
19. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
